ASCO

ASCO

Offline Online

Autoimmune can be delayed in immunotherapy Fadi Braiteh, MD

622 0 Acute Lymphoblastic Leukemia
Play
Want to watch this again later?
Sign in to add this video to a playlist. Login

Date added (newest)

ANG1005 shows promise for patients with leptomenigeal disease

ANG1005 shows promise for patients with leptomenigeal disease

Predictive and Prognostic biomarkers for Brain Metastasis

Predictive and Prognostic biomarkers for Brain Metastasis

ANG1005 side effect profile

ANG1005 side effect profile

ANG1005 shows promise in Brain Cancer

ANG1005 shows promise in Brain Cancer

Blood Brain Barrier and TKI in Brain Cancer treatment

Blood Brain Barrier and TKI in Brain Cancer treatment

Treating Brain Metastasis is being redefined due to genomic profiling

Treating Brain Metastasis is being redefined due to genomic profiling

PD-L1 and Triple Negative Breast Cancer

PD-L1 and Triple Negative Breast Cancer

Current and future Immunotherapy outlook in breast cancer from Annual Meeting 2016

Current and future Immunotherapy outlook in breast cancer from Annual Meeting 2016

PALOMA trials summary and Palbociclib in ER-positive breast cancer

PALOMA trials summary and Palbociclib in ER-positive breast cancer

Important to biopsy a growing lesion in lung cancer

Important to biopsy a growing lesion in lung cancer

Some patients saw dramatic improvement in IMvigor 210 trial

Some patients saw dramatic improvement in IMvigor 210 trial

Are safety and adverse event profile appears similar between early trials in both Anti PD-1 and Anti PD-L1

Are safety and adverse event profile appears similar between early trials in both Anti PD-1 and Anti PD-L1

ANG1005 shows promise for patients with leptomenigeal disease

1079 0 Acute Lymphoblastic Leukemia

Manmeet Ahluwalia, MD of the Cleveland Clinic Cancer Center discusses how ANG1005 shows promise for patients with leptomenigeal disease

Want to watch this again later?
Sign in to add this video to a playlist. Login

Predictive and Prognostic biomarkers for Brain Metastasis

769 0 Acute Lymphoblastic Leukemia

Manmeet Ahluwalia, MD from Cleveland Clinic Cancer Center and the Predictive and Prognostic biomarkers for Brain Metastasis

Want to watch this again later?
Sign in to add this video to a playlist. Login

ANG1005 side effect profile

619 0 Acute Lymphoblastic Leukemia

Manmeet Ahluwalia, MD of Cleveland Clinic Cancer Center discusses the side effect profile of ANG1005 from ASCO 2016

Want to watch this again later?
Sign in to add this video to a playlist. Login

ANG1005 shows promise in Brain Cancer

622 0 Acute Lymphoblastic Leukemia

Manmeet Ahluwalia, MD of Cleveland Clinic Cancer Center outlines how ANG1005 shows promise in Brain Cancer at ASCO 2016

Want to watch this again later?
Sign in to add this video to a playlist. Login

Blood Brain Barrier and TKI in Brain Cancer treatment

725 0 Acute Lymphoblastic Leukemia

Manmeet Ahluwalia, MD of Cleveland Clinic Cancer Center discusses Blood Brain Barrier and TKI in Brain Cancer treatment at ASCO 2016

Want to watch this again later?
Sign in to add this video to a playlist. Login

Treating Brain Metastasis is being redefined due to genomic profiling

938 0 Acute Lymphoblastic Leukemia

Manmeet Ahluwalia, MD of Cleveland Clinic Cancer Center discusses Treating Brain Metastasis is being redefined due to genomic profiling from ASCO 2016

Want to watch this again later?
Sign in to add this video to a playlist. Login

PD-L1 and Triple Negative Breast Cancer

639 0 Acute Lymphoblastic Leukemia

Jame Abraham, MD discusses PD-L1 in Triple Negative Breast Cancer from ASCO 2016

Want to watch this again later?
Sign in to add this video to a playlist. Login

Current and future Immunotherapy outlook in breast cancer from Annual Meeting 2016

885 0 Acute Lymphoblastic Leukemia

Jame Abraham, MD @CleClinicMD Cleveland Clinic Cancer Center highlights the Current and future Immunotherapy outlook in breast cancer from ASCO 2016

Want to watch this again later?
Sign in to add this video to a playlist. Login

PALOMA trials summary and Palbociclib in ER-positive breast cancer

649 0 Acute Lymphoblastic Leukemia

Dr. Jame Abraham, MD of the Cleveland Clinic Cancer Center @CleClinicMD discusses the PALOMA trials summary and Palbociclib in ER-positive breast cancer

Want to watch this again later?
Sign in to add this video to a playlist. Login

Important to biopsy a growing lesion in lung cancer

353 0 Acute Lymphoblastic Leukemia

Ramaswamy Govindan, MD of Washington University Medical School describes the importance to biopsy a growing lesion in lung cancer

Want to watch this again later?
Sign in to add this video to a playlist. Login

Some patients saw dramatic improvement in IMvigor 210 trial

420 0 Acute Lymphoblastic Leukemia

Evan Yu, MD of Seattle Cancer Care Alliance notes that some patients saw dramatic improvement in IMvigor210 trial

Want to watch this again later?
Sign in to add this video to a playlist. Login

Are safety and adverse event profile appears similar between early trials in both Anti PD-1 and Anti PD-L1

248 0 Acute Lymphoblastic Leukemia

Petros Grivas, MD of Cleveland Clinic asked the question Are safety and adverse event profile appears similar between early trials in both Anti PD-1 and Anti PD-L1

Want to watch this again later?
Sign in to add this video to a playlist. Login
My videos
ANG1005 shows promise for patients with leptomenigeal disease

ANG1005 shows promise for patients with leptomenigeal dis...
Manmeet Ahluwalia, MD of the Cleveland Clinic Cancer Center discusses how ANG1005 shows promise for patients with leptomenigeal disease
1,079 Views
6 years Ago
Want to watch this again later?
Sign in to add this video to a playlist. Login
Predictive and Prognostic biomarkers for Brain Metastasis
Predictive and Prognostic biomarkers for Brain Metastasis
769 Views
6 years Ago
ASCO
Want to watch this again later?
Sign in to add this video to a playlist. Login
ANG1005 side effect profile
ANG1005 side effect profile
619 Views
6 years Ago
ASCO
Want to watch this again later?
Sign in to add this video to a playlist. Login
ANG1005 shows promise in Brain Cancer
ANG1005 shows promise in Brain Cancer
622 Views
6 years Ago
ASCO
Want to watch this again later?
Sign in to add this video to a playlist. Login
Blood Brain Barrier and TKI in Brain Cancer treatment
Blood Brain Barrier and TKI in Brain Cancer treatment
725 Views
6 years Ago
ASCO
Want to watch this again later?
Sign in to add this video to a playlist. Login
Treating Brain Metastasis is being redefined due to genomic profiling
Treating Brain Metastasis is being redefined due to genom...
938 Views
6 years Ago
ASCO
Want to watch this again later?
Sign in to add this video to a playlist. Login
PD-L1 and Triple Negative Breast Cancer
PD-L1 and Triple Negative Breast Cancer
639 Views
6 years Ago
ASCO
Want to watch this again later?
Sign in to add this video to a playlist. Login
Current and future Immunotherapy outlook in breast cancer from Annual Meeting 2016
Current and future Immunotherapy outlook in breast cancer...
885 Views
6 years Ago
ASCO
Want to watch this again later?
Sign in to add this video to a playlist. Login
PALOMA trials summary and Palbociclib in ER-positive breast cancer
PALOMA trials summary and Palbociclib in ER-positive brea...
649 Views
6 years Ago
ASCO
Want to watch this again later?
Sign in to add this video to a playlist. Login
Important to biopsy a growing lesion in lung cancer
Important to biopsy a growing lesion in lung cancer
353 Views
6 years Ago
ASCO
Want to watch this again later?
Sign in to add this video to a playlist. Login
Some patients saw dramatic improvement in IMvigor 210 trial
Some patients saw dramatic improvement in IMvigor 210 trial
420 Views
6 years Ago
ASCO
Want to watch this again later?
Sign in to add this video to a playlist. Login
Are safety and adverse event profile appears similar between early trials in both Anti PD-1 and Anti PD-L1
Are safety and adverse event profile appears similar betw...
248 Views
6 years Ago
ASCO
Want to watch this again later?
Sign in to add this video to a playlist. Login
Annual Meeting 2016 update on Small Cell Lung Cancer agents
Annual Meeting 2016 update on Small Cell Lung Cancer agents
460 Views
6 years Ago
ASCO
Want to watch this again later?
Sign in to add this video to a playlist. Login
Previous cytotoxin patients thought they were on placebo during atezolizumab trial due to low toxicity side effects
Previous cytotoxin patients thought they were on placebo ...
218 Views
6 years Ago
ASCO
Want to watch this again later?
Sign in to add this video to a playlist. Login
IMvigor210 response rate durability of response and stable disease
IMvigor210 response rate durability of response and stabl...
293 Views
6 years Ago
ASCO
Want to watch this again later?
Sign in to add this video to a playlist. Login
POPLAR trial endpoints median duration of response overall survival and the impact of PD-L1 expression
POPLAR trial endpoints median duration of response overal...
277 Views
6 years Ago
ASCO
Want to watch this again later?
Sign in to add this video to a playlist. Login
Second line treatment of NSCLC patients before immuno-oncology
Second line treatment of NSCLC patients before immuno-onc...
608 Views
6 years Ago
ASCO
Want to watch this again later?
Sign in to add this video to a playlist. Login
All comers are eligible in second line urothelial cancer with Atezolizumab
All comers are eligible in second line urothelial cancer ...
472 Views
6 years Ago
ASCO
Want to watch this again later?
Sign in to add this video to a playlist. Login
Annual Meeting 2016 update on MET in NSCLC
Annual Meeting 2016 update on MET in NSCLC
451 Views
6 years Ago
ASCO
Want to watch this again later?
Sign in to add this video to a playlist. Login
Some patients saw dramatic improvement in IMvigor 210 trial
Some patients saw dramatic improvement in IMvigor 210 trial
434 Views
6 years Ago
ASCO
Want to watch this again later?
Sign in to add this video to a playlist. Login
POPLAR trial success leads to larger OAK study
POPLAR trial success leads to larger OAK study
620 Views
6 years Ago
ASCO
Want to watch this again later?
Sign in to add this video to a playlist. Login
Autoimmune can be delayed in immunotherapy
Autoimmune can be delayed in immunotherapy
542 Views
6 years Ago
ASCO
Want to watch this again later?
Sign in to add this video to a playlist. Login
Phase II POPLAR trial evaluating Atezolizumab in advanced NSCLC
Phase II POPLAR trial evaluating Atezolizumab in advanced...
522 Views
6 years Ago
ASCO
Want to watch this again later?
Sign in to add this video to a playlist. Login
Nivolumab and Pembrolizumab experience in the second line therapy of your NSCLC patients
Nivolumab and Pembrolizumab experience in the second line...
881 Views
6 years Ago
ASCO
Want to watch this again later?
Sign in to add this video to a playlist. Login
Phase III NEMO trial and the novel MEK inhibitor Binimetinib
Phase III NEMO trial and the novel MEK inhibitor Binimetinib
913 Views
6 years Ago
ASCO
Want to watch this again later?
Sign in to add this video to a playlist. Login
Loading